Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation.

BMC Medical Research Methodology
Lukas P StaubLes Irwig

Abstract

Before a new test is introduced in clinical practice, evidence is needed to demonstrate that its use will lead to improvements in patient health outcomes. Studies reporting test accuracy may not be sufficient, and clinical trials of tests that measure patient health outcomes are rarely feasible. Therefore, the consequences of testing on patient management are often investigated as an intermediate step in the pathway. There is a lack of guidance on the interpretation of this evidence, and patient management studies often neglect a discussion of the limitations of measuring patient management as a surrogate for health outcomes. We discuss the rationale for measuring patient management, describe the common study designs and provide guidance about how this evidence should be reported. Interpretation of patient management studies relies on the condition that patient management is a valid surrogate for downstream patient benefits. This condition presupposes two critical assumptions: the test improves diagnostic accuracy; and the measured changes in patient management improve patient health outcomes. The validity of this evidence depends on the certainty around these critical assumptions and the ability of the study design to minimise...Continue Reading

References

Jul 18, 1977·JAMA : the Journal of the American Medical Association·H V FinebergM Sosman
Apr 1, 1991·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D G Fryback, J R Thornbury
Nov 18, 1995·BMJ : British Medical Journal·P P Glasziou, L M Irwig
Apr 17, 2001·Annals of Internal Medicine·D MoherUNKNOWN CONSORT GROUP (Consolidated Standards of Reporting Trials)
Jul 31, 2001·Radiology·M G GillanUNKNOWN Scottish Back Trial Group
Jan 7, 2003·Annals of Internal Medicine·Patrick M BossuytUNKNOWN Standards for Reporting of Diagnostic Accuracy
Mar 20, 2004·Radiology·Fiona J GilbertUNKNOWN Scottish Back Trial Group
May 6, 2006·BMJ : British Medical Journal·Patrick M BossuytPaul Glasziou
Oct 19, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Bruce E HillnerBarry A Siegel
Mar 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce E HillnerR Edward Coleman
May 14, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nehmat HoussamiLes Irwig
May 17, 2008·BMJ : British Medical Journal·Holger J SchünemannUNKNOWN GRADE Working Group
Sep 17, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Andrew M ScottPeter Lin
Nov 11, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Bruce E HillnerR Edward Coleman
Jan 21, 2009·BMC Medical Research Methodology·Catherine A Meads, Clare F Davenport
Jul 17, 2009·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Jeroen G LijmerPatrick M M Bossuyt
Dec 8, 2009·The International Journal of Cardiovascular Imaging·Ronald P KarlsbergDaniel S Berman
Jan 13, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shelly S LoKathy S Albain
Aug 25, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Ian G StiellGeorge A Wells
Jan 11, 2012·International Journal of Technology Assessment in Health Care·Lukas P StaubR John Simes

❮ Previous
Next ❯

Citations

Dec 4, 2012·Alzheimer Disease and Associated Disorders·Michael GrundmanUNKNOWN 45-A17 Study Group
Nov 14, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Bruce E HillnerBarry A Siegel
Aug 12, 2014·Expert Review of Molecular Diagnostics·Felix W Frueh, Bruce Quinn
Mar 1, 2014·Current Medical Research and Opinion·E David CrawfordMichael K Brawer
Oct 16, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Simona FerraroMauro Panteghini
Jan 16, 2016·AJNR. American Journal of Neuroradiology·A SpinazziM A Kirchin
Sep 2, 2016·European Respiratory Review : an Official Journal of the European Respiratory Society·Mark Hew, Tunn Ren Tay
Jan 26, 2021·Practical Laboratory Medicine·Tony Badrick
Dec 2, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Bruce E HillnerBarry A Siegel
Dec 30, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ilana F GareenBarry A Siegel
Mar 3, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Rodney J Hicks
Jan 16, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Michael M Graham, Wolfgang A Weber

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

PLoS Neglected Tropical Diseases
Peter Hotez
The Journal of the American Dental Association
P M Sfikas
El Protesista dental
J J Bianchi
Delaware Medical Journal
Bruce D Armon, James D Taylor
Ugeskrift for laeger
A Gammelgaard
© 2022 Meta ULC. All rights reserved